Sleep and Circadian Rhythms in Tuberous Sclerosis Complex

结节性硬化症的睡眠和昼夜节律

• 批准号: 8609049
• 负责人: Jonathan Oren Lipton
• 金额: $ 13.35万
• 依托单位: BOSTON CHILDREN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-03-15 至 2017-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8609049
• 关键词: Academic Training; Affect; Anabolism; Animal Behavior; Animals; Autistic Disorder; Award; Behavior; Behavioral; Biochemical; Boston; Brain; Brain Diseases; Cells; Characteristics; Child; Childhood; Circadian Rhythms; Clinical; Clock protein; Commit; Complex; Data; Data Analyses; Development; Disease; Electroencephalography; Electromyography; Environment; Epilepsy; Experimental Designs; Food; Foundations; Fragile X Syndrome; Functional disorder; Gene Expression; Genes; Goals; Hamartoma; Health; Homeostasis; Hypothalamic structure; Injection of therapeutic agent; Intellectual functioning disability; Investigation; Israel; Knockout Mice; Lead; Light; Link; Macrocephaly; Maintenance; Measures; Mediating; Medical center; Medicine; Mentors; Mentorship; Metabolic; Metabolic Control; Metabolism; Molecular; Monitor; Morbidity - disease rate; Mus; Muscle Tonus; Mutate; Mutation; Neurodevelopmental Disorder; Neurofibromatosis 1; Neurologic; Neurologist; Neuronal Plasticity; Nutrient; PTEN gene; Pathogenesis; Pathway interactions; Patients; Pattern; Pediatric Hospitals; Personal Satisfaction; Phosphorylation; Physicians; Physiologic Thermoregulation; Physiological; Physiology; Proteins; REM Sleep; Regulation; Reporting; Rest; Ribosomal Protein S6 Kinase; Role; Science; Scientist; Seizures; Signal Pathway; Signal Transduction; Sleep; Sleep Deprivation; Sleep Disorders; Sleep Wake Cycle; Slow-Wave Sleep; Specialist; Stimulus; Structure; Syndrome; System; TSC1 gene; TSC1/2 gene; Testing; Time; Training; Tuberous sclerosis protein complex; Viral; base; career; circadian pacemaker; driving behavior; experience; in vivo; insight; knockout animal; loss of function; mTOR protein; medical schools; mouse model; neurodevelopment; neurogenetics; particle; psychologic; research study; ribosomal protein S6 kinase 1; sleep regulation; suprachiasmatic nucleus; tumor

DESCRIPTION (provided by applicant): Sleep is a ubiquitous yet mysterious animal behavior. Mounting evidence points to a crucial role for normal sleep in health and disease. This may be especially true for children with neurodevelopmental disorders such as Tuberous Sclerosis Complex (TSC). TSC is a neurogenetic syndrome that results from mutations in either the Tsc1 or Tsc2 genes that cause epilepsy, intellectual disability, and autism. Sleep dysfunction is reported in 50-90% of children with TSC and adversely affects daytime behavior, seizure control, metabolic homeostasis and psychological well- being. Treatment of sleep disorders in TSC and other neurodevelopmental syndromes has been limited by a fundamental lack of understanding of the mechanistic underpinnings of sleep dysfunction in these conditions. The proteins encoded by Tsc1 and Tsc2 inhibit the function of the mammalian target of rapamycin (mTOR), a conserved and critical integrator of nutrient status and anabolism in all cells. Dr. Lipton has used mouse models for TSC to establish a mechanistic link between the causes of TSC and the essential circadian clock protein BMAL1. These findings lead to the hypothesis that the Tsc/mTOR pathway is critical to the function of the central timekeeping mechanism in the brain, the suprachiasmatic nucleus of the hypothalamus (SCN). To test this hypothesis, the current mentored training plan has the following aims: (1) Determine the necessity and sufficiency of Tsc/mTOR signaling in the brain's central timekeeper, the suprachiasmatic nucleus (SCN); (2) Demonstrate the physiological requirement for Tsc/mTOR/S6K1-mediated phosphorylation of the crucial clock protein BMAL1 in vivo; (3) Determine the roles of TSC1/2 in sleep maintenance and homeostasis. These studies will establish the molecular role of the Tsc/mTOR pathway in the regulation of sleep and circadian rhythms. These studies will be carried at Children's Hospital Boston and Beth-Israel Deaconess Medical Center within the auspices of Harvard Medical School, under the dual mentorship of Dr. Clifford Saper, a renowned sleep scientist and neuroanatomist, and Dr. Mustafa Sahin, a child neurologist and pioneer in the understanding of the neurological basis for TSC. The Harvard Division of Sleep Medicine under the direction of Dr. Charles Czeisler provides a fertile environment for multi-disciplinary, cross-institutional academic training in sleep science and medicine at the highest level. Dr. Lipton is a child neurologist and sleep specialist with the career goal of becoming an independent physician-scientist committed to understanding the role of sleep and circadian rhythms in neurodevelopmental disorders. This mentored award will provide Dr. Lipton the structured training experience in experimental design and practice, didactics, and data analysis that will greatly facilitate the transition to a career as an independent physician-scientist.

描述（申请人提供）：睡眠是一种普遍存在但神秘的动物行为。越来越多的证据表明，正常睡眠在健康和疾病中起着至关重要的作用。对于患有神经发育障碍的儿童，如多发性硬化症（TSC），尤其如此。TSC是一种神经遗传综合征，由Tsc 1或Tsc 2基因突变引起，可导致癫痫、智力残疾和自闭症。据报道，50-90%的TSC儿童存在睡眠功能障碍，并对日间行为、癫痫控制、代谢稳态和心理健康产生不利影响。TSC和其他神经发育综合征中睡眠障碍的治疗受到限制，因为对这些条件下睡眠功能障碍的机制基础缺乏了解。由Tsc 1和Tsc 2编码的蛋白质抑制哺乳动物雷帕霉素靶蛋白（mTOR）的功能，mTOR是所有细胞中营养状态和粘附的保守和关键整合剂。Lipton博士使用TSC的小鼠模型来建立TSC的原因与基本生物钟蛋白BMAL 1之间的机制联系。这些发现导致了Tsc/mTOR通路对大脑中的中央计时机制（下丘脑的视交叉上核（SCN））的功能至关重要的假设。为了验证这一假设，目前的指导训练计划有以下目标：（1）确定Tsc/mTOR信号在大脑的中央计时器-视交叉上核（SCN）中的必要性和充分性;（2）证明Tsc/mTOR/S6 K1介导的关键时钟蛋白BMAL 1磷酸化的体内生理需求;（3）确定TSC 1/2在睡眠维持和稳态中的作用。这些研究将确立Tsc/mTOR通路在调节睡眠和昼夜节律中的分子作用。这些研究将在哈佛医学院赞助下的波士顿儿童医院和Beth-Israel Deaconess医疗中心进行，由著名睡眠科学家和神经解剖学家Clifford Saper博士和儿童神经学家Mustafa Sahin博士共同指导。在Charles Czeisler博士的指导下，哈佛睡眠医学部为最高水平的睡眠科学和医学的多学科，跨机构学术培训提供了肥沃的环境。Lipton博士是一名儿童神经学家和睡眠专家，其职业目标是成为一名独立的医生-科学家，致力于了解睡眠和昼夜节律在神经发育障碍中的作用。这个指导奖将为Lipton博士提供实验设计和实践，教学法和数据分析方面的结构化培训经验，这将极大地促进向独立医生-科学家职业生涯的过渡。